Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

With neuropathy, CBD research is even more limited ... CBD oil is relatively new as a treatment for many conditions. Research is limited. But the research that does exist shows a great deal ...

Research shows neuropathy can be more severe and more common in Black breast cancer patients, causing doctors to dial back ...

Living with a chronic pain condition can make everyday tasks more challenging. For some people in Southern Utah dealing with ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) stock is trading higher on Monday after the company released new preclinical ...

New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...

Jiangsu Alicorn Pharmaceutical Co. Ltd. has described AP2-associated protein kinase 1 (AAK1) inhibitors reported to be useful for the treatment of Alzheimer’s disease, bipolar disorder, Parkinson’s ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With ...

After experiencing cancer himself, one local doctor is preparing to run the 2024 New York City Marathon to raise money and ...

After experiencing cancer himself, one local doctor is preparing to run the 2024 New York City Marathon to raise money and ...

When you think of the YMCA, you might think of working out. But the "Y's" Thriver's Club is about more than making your ...

Cantargia (Cantargia AB); (Nasdaq Stockholm:CANTA) today announced new clinical results from two nadunolimab combination therapy trials ...